To view this email as a web page, click here.
 
NEW DRUG APPROVALS
 
New Parkinson's drug, 2 others approved
FDA approved safinamide (Xadago) as an add-on treatment for patients with Parkinson's disease, along with a drug for classical Hodgkin lymphoma and one to treat pemphigus vulgaris, a rare, life-threatening disease.
Read about 2 more
 
First drug for rare skin cancer gets approval
FDA approved the first treatment for metastatic Merkel cell carcinoma (MCC), a rare, aggressive skin cancer.
Read more
 
Gottlieb FDA nomination praised
Pharmaceutical manufacturers and some consumer groups praised President Donald Trump's nomination of Scott Gottlieb, MD, as the new FDA commissioner.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.